Authors of a prospective analysis followed 467,200 adults (mean age 57; 38% with metabolic syndrome) for a median of 15 years. Having metabolic syndrome—defined as ≥3 of central obesity, hypertension, hyperglycemia, low high-density lipoprotein, or high triglycerides—was associated with an approximately 40% higher likelihood of developing Parkinson’s disease (PD). Incidence rates were 4.87 vs 5.21 per 10,000 person-years for those without vs with metabolic syndrome, respectively, and risk appeared greater in people who also had genetic susceptibility to PD. The association persisted after adjustment for age, smoking status, physical activity, and PD-risk genetic variants. These findings align with prior work implicating components of metabolic syndrome (eg, elevated blood pressure, triglycerides, fasting glucose, and abdominal obesity) in higher PD risk.
Because metabolic syndrome is common and modifiable, investigators suggest that optimizing metabolic health could be a potential strategy for PD risk reduction, especially in genetically susceptible individuals. Clinically, this points to intensified midlife screening and management of weight, blood pressure, glucose, and lipids, alongside physical activity and diet counseling. Additional studies are needed to test whether treating metabolic syndrome can meaningfully lower PD risk. Future interventional or Mendelian randomization studies could help clarify causality and quantify the benefit of targeted metabolic interventions on PD incidence.
Reference: Livingston R. Dyslipidemia, Other Metabolic Syndrome Factors May Raise Parkinson’s Disease Risk. HCP Live. Published August 21, 2025. Accessed October 24, 2025. https://www.hcplive.com/view/dyslipidemia-other-metabolic-syndrome-factors-may-raise-parkinson-s-disease-risk
